BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Deals

  Caliper Life Sciences Completes Previously Announced CRi Acquisition

  December 21, 2010

   · 

  2 min read
• Biotech Bay

  Poniard Pharmaceuticals, Inc. Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility

  December 21, 2010

   · 

  5 min read
• Pharm Country

  Auxilium Pharmaceuticals to Present at the 2011 29th Annual J.P. Morgan Healthcare Conference

  December 21, 2010

   · 

  4 min read
• Business

  Silence Therapeutics plc Provides Year-end Update

  December 21, 2010

   · 

  3 min read
• BioMidwest

  Los Alamos National Laboratory Announces Top 10 Science & Technology Developments of 2010

  December 21, 2010

   · 

  1 min read
• Policy

  AstraZeneca PLC Takes $445 Million Charge on Failure of MedImmune RSV Therapy

  December 21, 2010

   · 

  1 min read
• Business

  Urodynamix Technologies Ltd. Announces Change in Directors and Officers

  December 21, 2010

   · 

  1 min read
• Business

  Pro-Pharmaceuticals, Inc. & Mount Sinai School of Medicine Announce New Liver Fibrosis Research Collaboration

  December 21, 2010

   · 

  1 min read
• Drug Development

  VBL Therapeutics Announces Initiation of Phase 2 Clinical Trial of VB-201 on hsCRP, Important Inflammation-Related Biomarker for Cardiovascular, Other Chronic Inflammatory Diseases

  December 21, 2010

   · 

  1 min read
• BioMidwest

  Allos Therapeutics, Inc.’ Marketing Authorisation Application (MAA) for FOLOTYN(R) Accepted for Review by European Medicines Evaluation Agency

  December 21, 2010

   · 

  1 min read